K086-0140 Screening compound: 5-(3-bromophenyl)-3-[4-(4-propylcyclohexyl)phenyl]-1,2,4-oxadiazole
Chemical Structure Depiction of ChemDiv screening compound K086-0140
5-(3-bromophenyl)-3-[4-(4-propylcyclohexyl)phenyl]-1,2,4-oxadiazole
Available from 1 mg
Formats:
- Glass Vials (4ml Glass Vials VWR #97047-678)
- 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)
Shiptime: 1 week worldwide delivery in most cases
Compound Identifiers
ChemDiv Compound ID
K086-0140
Molecular Formula
C23H25BrN2O (C23 H25 BrN2 O)
Compound Name
5-(3-bromophenyl)-3-[4-(4-propylcyclohexyl)phenyl]-1,2,4-oxadiazole
IUPAC name
5-(3-bromophenyl)-3-[4-(4-propylcyclohexyl)phenyl]-124-oxadiazole
SMILES
CCCC(CC1)CCC1c(cc1)ccc1-c1noc(-c2cccc(Br)c2)n1
InChI Key
MDL Number (MFCD)
Chemical and Physical Properties
Saltdata
n/a
Molecular Weight
425.37
Hydrogen Bond Acceptors Count
3.00
Hydrogen Bond Donors Count
0.00
Rotatable Bond Count
5.00
Number of Nitrogen and Oxygen Atoms
3
Partition Coefficient, logP
8.738
Distribution Coefficient, logD
8.738
Water Solubility, LogSw
-5.91
Polar Surface Area
31.565
Acid Dissociation Constant (pKa)
23.96
Base Dissociation Constant (pKb)
-4.89
Number of Chiral Centers
0.00
Percent sp3 carbon bonding
39.10
References: we are preparing a list of scientific research reports with K086-0140 chemical compound. It will be published here after verification.
Frequently Asked Questions
Check Price and Availability of K086-0140, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
Available from 1 mg in Glass Vials or 96-tube racks.
ChemDiv sends parcels with Express services (UPS, WC).
- 1–2 days for small orders
- 2–4 weeks for large selections
- 0.5–50 mg of dry powder sample in single glass vials, custom vials
- DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)